Clinical Trial Update: Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above [Phase 1]

View source ↗

Summary

This entry updates a Phase 1 clinical trial of a lyophilized mRNA vaccine for respiratory syncytial virus in adults; the study is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Lyophilized Respiratory Syncytial Virus mRNA Vaccine

Snippet

Sponsor: Suzhou Abogen Biosciences Co., Ltd. | Conditions: Respiratory Syncytial Virus | Phase 1 | Status: ACTIVE_NOT_RECRUITING